The UC Irvine Podcast

The green streak continues! Sierra magazine has named the University of California, Irvine No. 1 in the nation and No. 2 overall in its annual “Cool Schools” ranking of sustainability leaders among U.S. and Canadian colleges. Learn more at http://news.uci.edu.

Money magazine has ranked the University of California, Irvine No. 1 on its 2019-20 list of the nation’s “Best Colleges.” In this episode of the UCI Podcast, host Sheri Ledbetter speaks with Willie Banks, UCI's vice chancellor for student affairs, to gain his perspective on why the university has earned this top college ranking.

This latest episode of The UCI Podcast goes onstage at the New Swan Shakespeare Festival with its creative director Eli Simon. The eighth season of popular theater series kicks off this July with two of the Bard’s most archetypal plays: “The Merchant of Venice” and “The Two Gentlemen of Verona.”

In this episode of the UCI Podcast, we meet with Mark Deppe, director of UCI Esports, and Avi Behar, jungler on the Anteaters collegiate champion League of Legends team who are defending their title this week. The two discuss the history and culture of the UCI Esports program and their excitement about competing in the College League of Legends championship.

This episode of The UCI Podcast features two interviews with University of California, Irvine faculty members. In our first conversation, we'll discuss the history of video games through the lens of LGBTQ theory with Bonnie "Bo" Ruberg, assistant professor of informatics, whose new book, "Video Games Have Always Been Queer," is on shelves now. Then we'll talk about what it takes to find exoplanets orbiting dim M-dwarf stars in the Milky Way with UCI assistant professor of astronomy Paul Robertson. Learn more by visiting news.uci.edu.

This first episode of The UCI Podcast features an interview with Kyriacos Athanasiou, Distinguished Professor of biomedical engineering at the University of California, Irvine. Athanasiou's group at UCI has been looking into ways to treat defects to the temporomandibular joint, which impact about a quarter of the population.